Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Cancer drug development Drug prices

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots - 9 days ago 3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - 3 months ago
2	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news you need to read today - 23 days ago The biotech news roundup to start your week - about 2 months ago Element Biosciences raises another massive round - 5 months ago The biotech news you missed this week - 6 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 7 months ago New data on liquid biopsy for colorectal cancer detection still underwhelms - 9 months ago Lawmakers want to add more Chinese biotechs to defense list - 9 months ago The Senate health committee looks into its first subpoena in 40 years - 11 months ago The biotech updates you need to read today - about 1 year ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - about 1 year ago FDA chastens pet companies over antibiotics - about 1 year ago The biotech news you missed from the weekend - about 1 year ago Novartis is building a new radioligand plant in China - about 1 year ago Today’s biotech news roundup, in under 800 words - about 1 year ago A new algorithm unveils CRISPR ‘treasure trove’ - about 1 year ago These are the need-to-know biotech stories from this weekend - about 1 year ago XBI biotech index rises, giving investors a shred of hope - about 1 year ago Your Monday morning biotech news roundup - about 1 year ago Candor on gene therapy, Abiomed is warned, & BTK success in MS - about 1 year ago Want a biotech buyout? Target cancer - about 1 year ago
3	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: It might be now or never for the BIOSECURE Act - 24 days ago STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - about 1 month ago
4	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: The state of biotech M&A 2024 - 29 days ago STAT+: Roche’s TIGIT study was a bust. What’s the outlook for its next big bet? - 5 months ago A biotech’s binary bet ends badly - 6 months ago STAT+: The inside story of Enhertu’s pan-tumor approval - 8 months ago STAT+: Weed for weight loss, and more from Biotech Land - 9 months ago STAT+: The biotech scorecard for the first quarter: 17 stock-moving events to watch - 12 months ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - about 1 month ago STAT+: Helsinki Declaration says researchers must disclose trial results on a timely basis - about 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 9 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 9 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - 9 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - about 1 year ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - about 1 year ago STAT+: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail - about 1 year ago
6	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	STAT+: Biotech analyst Brian Skorney and CEO Daphne Zohar weigh in on election results - about 1 month ago The biotech updates you need to read this morning - 2 months ago
7	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - about 1 month ago
8	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - about 1 month ago
9	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present - 3 months ago STAT+: With biotech in a slump, the industry’s job market is upside down - about 1 year ago STAT+: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise - about 1 year ago
10	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Who’s winning in biotech’s tight market? - 3 months ago

Journalists covering biotech reporting